Home > Insider Trading > Filing (0001209191-14-017982)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1009356	Salix Pharmaceuticals Ltd	SLXP	Pharmaceutical Preparations (2834)	943267443

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1053880	F John Chappell	8510 Colonnade Center Drive Raleigh NC 27615		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2014-03-04	10,000	$112.20	460,834	No	4	S	Direct
Common Stock	Disposition	2014-03-05	240	$0.00	460,594	No	4	G	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	G	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	8,200	Indirect	By Spouse
Common Stock	50,000	Indirect	By GRAT

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Option to Buy Common Stock	$17.63		2015-06-09	15,000	15,000	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2015-06-09	15,000	15,000	Direct

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $112.03 to $112.36, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
Options are 100% vested.